Siemens Healthcare Diagnostics – PFA-100 Platelet Function Analyzer
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH) Clinical Center plans to award a sole-source, firm-fixed-price purchase order to Siemens Healthcare Diagnostics for one new PFA-100 Platelet Function Analyzer along with a barcode scanner and cable. This acquisition is driven by the need to replace an existing instrument that has exceeded its service life and is no longer reliable, ensuring continuous platelet function testing essential for patient care and clinical research. The PFA-100 system plays a critical role in specialized coagulation testing, supporting clinical laboratory operations at NIH by enhancing testing accuracy and reducing manual labor. Siemens Healthcare Diagnostics is the only source capable of providing a new analyzer compatible with the existing validated testing methods, proprietary cartridges, reagents, and laboratory workflows used by NIH. Introducing an alternative platform would necessitate extensive validation efforts and risk disruptions in patient care. The purchase is conducted under a sole-source authority that exempts it from full competition requirements. Although this is not a solicitation for quotations, interested vendors may submit capability statements demonstrating their ability to meet the requirements by June 24, 2026. The NIH will review these statements at its discretion, focusing on technical capability, compatibility with current methodologies, manufacturer authorization, and past performance.
General Info
Agency
NAICS
Place of Performance
MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Title: Siemens Healthcare Diagnostics – PFA-100 Platelet Function Analyzer
Product Service Code (PSC): 6630 – Chemical Analysis Instruments and Apparatus
NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing
Place of Performance:
National Institutes of Health (NIH)
Clinical Center
Bethesda, MD 20892
Description
This notice is issued for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Clinical Center, intends to award a sole-source firm-fixed-price purchase order to Siemens Healthcare Diagnostics for the acquisition of one (1) new PFA-100 Platelet Function Analyzer.
The following items are needed for this order:
Quantity/ Part Number/ Description of Equipment
1/10459298/PFA 100
1/11539138/Barcode Scanner/Cable-PFA-100
The Department of Laboratory Medicine requires a replacement PFA-100 Platelet Function Analyzer to ensure uninterrupted platelet function testing in support of patient care and NIH clinical research activities. The existing instrument has exceeded its expected service life and is no longer operating reliably.
Background
The Department of Laboratory Medicine serves as the clinical laboratory for the NIH Clinical Center and provides laboratory support for patient care, clinical research protocols, and training in clinical pathology. The PFA-100 system is utilized for special coagulation testing and supports critical clinical patient testing while reducing labor requirements and minimizing manual testing errors.
Rationale
The PFA-100 utilizes proprietary manufacturer-specific cartridges, reagents, and validated methodologies that are not compatible with alternative testing platforms. Siemens Healthcare Diagnostics is the only source capable of providing a new instrument that maintains compatibility with existing validated testing methods, laboratory workflows, and clinical result interpretation standards. Substitution of another platform would require extensive validation and verification studies and could adversely impact patient care operations.
Authority
This acquisition is being conducted in accordance with FAR 13.106-1(b)(1) – Soliciting from a Single Source. Under this authority, the Contracting Officer may solicit from a single source when it is determined that only one source is reasonably available to meet the Government's requirements. Acquisitions conducted under FAR Part 13 are exempt from the competition requirements of FAR Part 6.
Responses
This is not a request for quotations. However, interested parties may submit a capability statement demonstrating their ability to provide an equivalent solution that fully meets the Government's requirements.
Responses must include:
• Company name and address
• Technical capability
• Documentation demonstrating compatibility with existing validated testing methods
• Proof of manufacturer authorization, if applicable
• Relevant past performance
The Government will evaluate capability statements received in response to this notice. The determination not to compete this requirement is solely within the discretion of the Government.
Submission Instructions
Responses must be submitted electronically to by June 24, 2026 at 11:30AMEST:
Shasheshe Goolsby
Team Leader
Hospital and Laboratory Support Division
Office of Acquisition and Logistics Management (OALM)
National Institutes of Health
Email: shasheshe.goolsby@nih.gov